AVITA MEDICAL WKN: A0Q40S ISIN: AU000000AVH4 Kürzel: AVMXF Forum: Aktien Thema: Hauptdiskussion

AVITA Medical Submits FDA PMA Supplement to Further Expand Indication to Soft Tissue Repair https://www.globenewswire.com/news-release/2022/12/12/2571977/0/en/AVITA-Medical-Submits-FDA-PMA-Supplement-to-Further-Expand-Indication-to-Soft-Tissue-Repair.html

Link zum Download der Präsentation von der Jahreshauptversammlung: 2022 Annual Meeting of Stockholders Presentation https://hotcopper.com.au/threads/ann-2022-annual-meeting-of-stockholders-presentation.7143595/

https://www.globenewswire.com/news-release/2022/11/21/2560279/0/en/AVITA-Medical-to-Present-at-the-Piper-Sandler-34th-Annual-Healthcare-Conference.html AVITA Medical® to Present at the Piper Sandler 34th Annual Healthcare Conference ...announced today that its management team will present at the Piper Sandler 34th Annual Healthcare Conference in New York on Wednesday, November 30, 2022, at 4:30 p.m. Eastern Time. ...

https://www.einnews.com/pr_news/601735565/avita-medical-to-host-investor-webinar-briefing AVITA Medical® to Host Investor Webinar Briefing ...invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Jim Corbett, CEO, and Michael Holder, CFO, on November 23, 2022 at 4:00pm (PST) / November 24, 2022 at 11:00am (AEDT). ....

Das könnte wirklich was werden. Danke für die regelmäßigen Updates!

https://www.globenewswire.com/news-release/2022/11/10/2553735/0/en/AVITA-Medical-Reports-Third-Quarter-2022-Financial-Results.html

https://themarketherald.com.au/avita-medical-asxavh-bolsters-revenue-guidance-reduces-quarterly-net-loss-2022-11-11/ Avita Medical (ASX:AVH) bolsters revenue guidance, reduces quarterly net loss

AVITA Medical Announces Achievement of Co-Primary Endpoints in Updated Analysis of Pivotal Trial of RECELL® System for Soft Tissue Repair https://www.globenewswire.com/news-release/2022/11/09/2552596/0/en/AVITA-Medical-Announces-Achievement-of-Co-Primary-Endpoints-in-Updated-Analysis-of-Pivotal-Trial-of-RECELL-System-for-Soft-Tissue-Repair.html

AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® System https://www.globenewswire.com/news-release/2022/11/04/2548463/0/en/AVITA-Medical-Announces-FDA-Breakthrough-Device-Designations-for-the-RECELL-System.html

😶

😁😊

Dumme Aktie , die nur von deutschen gehandelt wird . Viel erfolg ....... ah ne das sagt man ja nur wenn auch Potenzial ist . In diesem Fall , viel Glück euch

🤷‍♂️ ReCell ein super Produkt, aber seit dem Split und dem Wechsel nach USA steht die Partie. Bin jedoch überzeugt, dass der weltweite Durchbruch früher oder später kommt 😉

Hat jemand genauere infos?

Hab bei 3,21 investiert